Effects of polypharmacy on sleep in psychiatric inpatients

Schizophrenia Research

Volumn 139, Issue 1-3, 2012, Pages 225-228

  Waters, Flavie ^a,b   Faulkner, Deborah ^b   Naik, Neepa ^b   Rock, Daniel ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b GRAYLANDS HOSPITAL   (Australia)

Author keywords

Antidepressants; Antipsychotic agents; Mental disorders; Sleep; SSRI

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; SEDATIVE AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENTAL PATIENT; PITTSBURGH SLEEP QUALITY INDEX; POLYPHARMACY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; FEMALE; HEALTH SURVEYS; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; POLYPHARMACY; QUESTIONNAIRES; SLEEP DISORDERS;

EID: 84863775625     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.05.013     Document Type: Article

References (12)

1. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67(3):255-262.
2. Argyropoulos S.V., Wilson S.J., Nutt D.J. The effects of antidepressant drugs and 5-HT1a agonists on human sleep. Serotonin and Sleep: Molecular, Functional and Clinical Aspects 2008, 569-585. Birkhauser Verlag, Switzerland. J.M. Monti, B.L. Jacobs, D.J. Nutt (Eds.).
3. Benson K., Zarcone V. Sleep abnormalities in schizophrenia and other psychotic disorders. Rev. Psychiatry, Am. Psychiatric Assoc. 1994, vol. 13:677-705. J.M. Oldham, M.B. Riba (Eds.).
4. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28(2):193-213.
5. Cohrs S. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 2008, 22(11):939-962.
6. DeMartinis N.A., Winokur A. Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol. Disord. Drug Targets 2007, 6(1):17-29.
7. Monteleone P., Martiadis V., Maj M. Circadian rhythms and treatment implications in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(7):1569-1574.
8. Royuela A., Macias J., Gil-Verona J., Pator J.F., Maniega M.A., Alonso J., Roman J.M., DePaz F., Barbosa M., Rami-Gozalez L., Boget T. Sleep in schizophrenia: a preliminary study using the Pittsburgh Sleep Quality Index. Neurobiol. Sleep-Wakefulness Cycle 2002, 2(2):37-39.
9. Takahashi K.I., Shimizu T., Sugita T., Saito Y., Takahashi Y., Hishikawa Y. Prevalence of sleep respiratory disorders in 101 schizophrenia inpatients. Psychiatry Clin. Neurosci. 1998, 52(2):229-231.
10. Winkelman J.W. Is schizophrenia a risk factor for obstructive sleep apnea?. Sleep Res. 1997, 305.
11. Winokur A., Kamath J. The effect of typical and atypical antipsychotic drugs on sleep in schizophrenia patietns. Serotonin and sleep: Molecular, functional and clinical aspects 2008, 587-610. Birkhauser Verlag, Switzerland. J.M. Monti, B.L. Jacobs, D.J. Nutt (Eds.).
12. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64(6):663-667.